These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23493758)

  • 41. Posttranscriptional regulation of insulin family ligands and receptors.
    Panda AC; Grammatikakis I; Yoon JH; Abdelmohsen K
    Int J Mol Sci; 2013 Sep; 14(9):19202-29. PubMed ID: 24051403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systematic Survey of the Role of IGF in the Link Between Diabetes and Cancer.
    Devanathan N; Kimble-Hill AC
    Indiana Univ J Undergrad Res; 2018; 4(1):17-26. PubMed ID: 30906876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of insulin and insulin-like growth factors on tumor vascularization: new insights of insulin-like growth factor family in cancer.
    Orciari S; Di Nuzzo S; Lazzarini R; Caprari P; Procopio A; Catalano A
    Curr Med Chem; 2009; 16(30):3931-42. PubMed ID: 19747131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis?
    Rensing KL; Houttuijn Bloemendaal FM; Weijers EM; Richel DJ; Büller HR; Koolwijk P; van der Loos CM; Twickler TB; von der Thüsen JH
    Diabetologia; 2010 May; 53(5):966-70. PubMed ID: 20182859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insulin and cancer: should one worry?
    Lefèbvre P
    Arch Physiol Biochem; 2008 Feb; 114(1):1-2. PubMed ID: 18465352
    [No Abstract]   [Full Text] [Related]  

  • 46. The Continuing Evolution of Insulin-like Growth Factor Signaling.
    Rosenzweig SA
    F1000Res; 2020; 9():. PubMed ID: 32226608
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin-like growth factor-related signaling and cancer development.
    Pollak M
    Recent Results Cancer Res; 2007; 174():49-53. PubMed ID: 17302184
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pleiotropic roles of the insulin-like growth factor axis in type 1 diabetes.
    Shapiro MR; Atkinson MA; Brusko TM
    Curr Opin Endocrinol Diabetes Obes; 2019 Aug; 26(4):188-194. PubMed ID: 31145130
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axis.
    Vella V; De Francesco EM; Bonavita E; Lappano R; Belfiore A
    Trends Endocrinol Metab; 2022 Aug; 33(8):569-586. PubMed ID: 35691786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin and insulin-like growth factors in the CNS.
    Baskin DG; Wilcox BJ; Figlewicz DP; Dorsa DM
    Trends Neurosci; 1988 Mar; 11(3):107-11. PubMed ID: 2465607
    [No Abstract]   [Full Text] [Related]  

  • 51. The IGF Hormonal Network in Endometrial Cancer: Functions, Regulation, and Targeting Approaches.
    Bruchim I; Sarfstein R; Werner H
    Front Endocrinol (Lausanne); 2014; 5():76. PubMed ID: 24904527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Role of the Insulin-Like Growth Factor 1 Pathway in Immune Tumor Microenvironment and Its Clinical Ramifications in Gynecologic Malignancies.
    Yahya MA; Sharon SM; Hantisteanu S; Hallak M; Bruchim I
    Front Endocrinol (Lausanne); 2018; 9():297. PubMed ID: 29922232
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The many faces of insulin-like peptide signalling in the brain.
    Fernandez AM; Torres-Alemán I
    Nat Rev Neurosci; 2012 Mar; 13(4):225-39. PubMed ID: 22430016
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin signaling pathways and cardiac growth.
    DeBosch BJ; Muslin AJ
    J Mol Cell Cardiol; 2008 May; 44(5):855-64. PubMed ID: 18423486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell death in the nervous system: lessons from insulin and insulin-like growth factors.
    Varela-Nieto I; de la Rosa EJ; Valenciano AI; León Y
    Mol Neurobiol; 2003 Aug; 28(1):23-50. PubMed ID: 14514984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Insulin and insulin-like growth factor pathway, a new targeted therapy in oncology].
    Bosch-Barrera J; Hernández A; Abella LE
    An Sist Sanit Navar; 2009; 32(3):413-21. PubMed ID: 20094103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complexity and stability in growing cancer cell populations.
    Gerlee P; Altrock PM
    Proc Natl Acad Sci U S A; 2015 May; 112(21):E2742-3. PubMed ID: 25941414
    [No Abstract]   [Full Text] [Related]  

  • 58. IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance?
    Belfiore A; Rapicavoli RV; Le Moli R; Lappano R; Morrione A; De Francesco EM; Vella V
    Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Advances in the studies of the link between diabetes and cancer].
    Yu JJ; Hua F; Hu ZW
    Yao Xue Xue Bao; 2016 Jul; 51(7):1017-24. PubMed ID: 29896947
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hallmarks of cancer: The insulin-like growth factors perspective.
    Werner H; LeRoith D
    Front Oncol; 2022; 12():1055589. PubMed ID: 36479090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.